Cardiovascular Imaging in the Era of Molecular Medicine: Nov. 29, 8:30am-12:00pm

This multisession course considers the clinical potential of molecular imaging in management of cardiovascular diseases. Experts review molecular methods for imaging plaque, stem cell labeling for noninvasive imaging, the future of cardiovascular molecular imaging and more.

When: Tuesday, Nov. 29, 8:30-12:00
Where: S502AB

Speaker information:

King C. Li, MD, director, department of translational imaging, Methodist Hospital Research Institute, Houston
Zahi Fayad, PhD, director, Translational and Molecular Imaging Institute, Mount Sinai Medical Center, New York City
Farouc Jaffer, MD, PhD, director, cardiovascular molecular imaging program, Massachusetts General Hospital, Boston

Around the web

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services.